| Literature DB >> 35410000 |
Marianna De Maio1, Cecilia Bratta1, Alice Iannaccone1, Loriana Castellani1, Carl Foster2, Cristina Cortis1, Andrea Fusco1.
Abstract
The role of physical activity in improving overall aspects of health regardless of age is well documented. Due to the coronavirus disease 2019 outbreak, preventive measures to limit airborne infection have been introduced, with people, especially older adults, advised to stay at home, thus increasing sedentary lifestyle and the risk of chronic diseases. As one of the few possible ways to stay active is home-based training, this review aims to provide evidence on alternative and feasible home-based activity programs as a tool to improve the fitness level in older adults, especially when preventive measures are needed to ensure isolation and limit interpersonal contacts. During quarantine, older adults, especially those with chronic diseases, are recommended to regularly exercise. Combined balance and muscle-strengthening training has proven to be particularly useful in limiting falls and mobility limitations. In addition, the use of virtual reality systems seems to be a potential strategy in remaining physically active, reducing physical inactivity time and significantly increasing the compliance of the older adults with physical activity programs. In conclusion, home-based programs induce improvements in physical functions in general and quality of life in older people with or without co-morbidities, and it can be considered in the future as one of the feasible and economic ways to increase physical well-being. This may be of unique importance in the setting of coronavirus disease 2019 enforced limitations in out-of-home activity.Entities:
Keywords: SARS-CoV-2; exercise; older adults; well-being
Mesh:
Year: 2022 PMID: 35410000 PMCID: PMC8998434 DOI: 10.3390/ijerph19074317
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
The principles of exercise prescription before COVID-19.
| References | Duration; | Intensity | Time | Type | Volume | Progression |
|---|---|---|---|---|---|---|
| [ | 6 to 24 months; | NA | 2 h | Balance | NA | NA |
| [ | 8 wk; | NA | NA | Balance | NA | NA |
| [ | 8 wk; | NA | NA | Balance | NA | NA |
| [ | 16 wk; | NA | 20 to 30 min | Balance | NA | NA |
| [ | 12 months; | NA | 40 min | Balance | NA | NA |
| [ | 4 wk; | NA | 60 min | Balance | NA | NA |
| [ | 12 wk; | Moderate to high | 60 min | Balance | NA | NA |
| [ | 8 wk; | Moderate to high | 40 min | Mobility | NA | NA |
| [ | 12 wk; | RPE 13/15 Borg 6-20 | 40 min | Mobility | NA | NA |
| [ | 6 months; | NA | NA | Mobility | NA | Resistance bands |
| [ | 6 months; | RPE 7/8 CR 10 | NA | Strength-resistance | 8 rep | NA |
| [ | 12 wk; | NA | NA | Strength-resistance | 10–15 rep | Resistance bands |
| [ | 12 months | NA | NA | Strength-resistance | NA | NA |
| [ | 12 wk; | RPE 12/16 Borg 6-20 | NA | Strength-resistance | 8–15 rep | NA |
NA: not applicable; d: day; x: the number of training days per week; wk: week; min: minute; h: hour; rep: repetitions; RPE: rate of perceived exertion; Borg: Borg scale from 6 to 20; CR 10: category-ratio at number 10.
The main outcomes before COVID-19.
| References | Outcomes (Δ) | Pre | Post | Diff. Pre-Post |
|---|---|---|---|---|
| [ | Cognitive status | 24.25 | 24.56 | 0.31 (AU) |
| ADL | 87.81 | 88.88 | 1.07 (AU) | |
| PHS | 7.8 | 8.13 | 0.33 (AU) | |
| SEE | 50.06 | 65.69 | 15.63 (AU) | |
| OEE | 49.25 | 47.69 | −1.56 (AU) | |
| [ | TUG | 15.04 | 12.1 | −2.94 (s) |
| BBS | 51 | 55 | 4 (AU) | |
| One-leg stance | 8.3 | 20.8 | 12.5 (s) | |
| Tandem standing | 21.2 | 35 | 13.8 (s) | |
| [ | Figure-of-8 running | 20.6 | 19.4 | −1.2 (s) |
| [ | Dynamic balance | 7.2 | 6.1 | −1.1 (s) |
| [ | Low grip strength | 15.71 | 18.84 | 3.13 (kg) |
| TUG | 12.21 | 10.33 | −1.88 (s) | |
| BBS | 49.12 | 52.68 | 3.56 (AU) | |
| VO2max | 26.53 | 27.59 | 1.06 (mL/kg/min) | |
| [ | Balance | 10.91 | 13.41 | 2.5 (s) |
| Gait speed | 6.25 | 8.25 | 2 (s) | |
| [ | 6MWT | 318.8 | 404.8 | 86 (m) |
| 15-m walking test | 15.9 | 12.7 | −3.2 (s) | |
| [ | Tandem walk | 47.9 | 30.9 | −17 (s) |
| One-legged stance | 8.5 | 15.7 | 7.2 (s) | |
| Maximal gait | 1.7 | 1.5 | −0.2 (m/s) | |
| 6MWT | 1227 | 1324 | 97 (ft) | |
| Hand grip | 21.8 | 22.4 | 0.6 (kg/f) | |
| Knee extension 1RM | 17.1 | 20.2 | 3.1 (kg) | |
| [ | TUG | 7.23 | 7.16 | −0.07 (s) |
| 4-m walk test | 0.98 | 1.04 | 0.06 (m/s) | |
| 5-times sit to stand | 11.68 | 10.58 | −1.1 (s) | |
| 4-step stair climb | 2.73 | 3.16 | 0.43 (s) | |
| SPPB | 11 | 11.3 | 0.3 (AU) | |
| [ | MWS | 102 | 111 | −2.2 (m/min) |
| TUG | 7.2 | 7 | −0.2 (s) | |
| RSTL | 26.9 | 25.9 | −1 (s) | |
| LSTL | 25.1 | 25.1 | 0 (s) | |
| [ | ROM | 102.7 | 100.5 | −2.2 (mm/s) |
| Stride velocity | 1.38 | 1.46 | 0.08 (m/s) | |
| TUG | 9.91 | 8.78 | −1.13 (s) |
Diff.: difference; ADL: activities of daily living; PHS: perceived health status; SEE: self-efficacy for exercise; OEE: outcome expectations for exercise; TUG: timed up and go; BBS: berg balance scale; 6MWT: 6-min walking test; 1RM: one repetition maximus; SPPB: short physical performance battery; MWS: maximum walking speed; RSTL: standing time on the right leg; LSTL: standing time on the left leg; ROM: range of motion; AU: arbitrary units; s: second; kg: kilogram; mL: milliliter; min: minute; ft: feet; mm: millisecond; m: meter.
The principles of exercise prescription of chronic diseases before COVID-19.
| References | Duration; | Intensity | Time | Type | Volume | Progression |
|---|---|---|---|---|---|---|
| [ | 6 months; | NA | NA | Stretching; balance; breathing; dual-tasks training | NA | NA |
| [ | Daily | Low-intensity | 15 min | Sitting calisthenics; | NA | NA |
| [ | 7 wk; | 30% Plmax | NA | Inspiratory training | NA | Increase 5% Plmax |
| [ | 6 months; | NA | NA | Function-oriented exercises | NA | NA |
| [ | 6 to 24 months; | NA | NA | Balance; strength | 8–10 rep; | NA |
| [ | 9 wk; | NA | NA | Strength-resistance | NA | NA |
| [ | 3 months; | NA | NA | Strength-resistance; balance | 12 rep | NA |
| [ | NA | High-intensity | NA | Strength-resistance | NA | NA |
| [ | 6 months; | 75% 1RM | 40 s | Strength; aerobic | NA | Increase 20% 1RM |
| [ | 6 d x wk | Low-intensity | 10 min | Intermittent walking | NA | NA |
NA: not applicable; d: day; x: the number of training days per week; wk: week; min: minute; s: second; rep: repetitions; Plmax: maximum inspiratory pressure; 1RM: one repetition maximum.
The main outcomes of chronic diseases before COVID-19.
| References | Outcomes (Δ) | Pre | Post | Diff. Pre-Post |
|---|---|---|---|---|
| [ | 5-min walking time | 2.96 | 2.78 | −0.18 (s) |
| TUG | 6.83 | 6.6 | −0.23 (s) | |
| Sit and reach test | 14.9 | 17.7 | 2.8 (cm) | |
| [ | 6MWD | 404 | 467 | 63 (m) |
| [ | SPPB | 5.9 | 6.3 | 0.4 (AU) |
| BBS | 40.8 | 45.6 | 4.8 (AU) | |
| Leg strength | 25.5 | 29.9 | 4.4 (AU) | |
| [ | TUG | 6.16 | 5.63 | −053 (s) |
| 5x chair rise | 10.95 | 9.54 | −1.41 (s) | |
| SPPB | 11.38 | 11.88 | 0.5 (AU) | |
| 10m test habitual | 1.38 | 1.43 | 0.05 (m/s) | |
| 10m test fast | 1.9 | 2.01 | 0.11 (m/s) | |
| [ | TUG | 9.67 | 8.82 | −0.85 (s) |
| 4m test | 4.47 | 3.71 | −0.76 (s) | |
| Gait speed | 0.9 | 1.11 | 0.21 (m/s2) | |
| Chair stand test | 12.29 | 11.41 | −0.88 (s) | |
| Handgrip strength | 19.2 | 18.68 | 0.52 (kg) |
Diff.: difference; TUG: timed up and go; 6MWD: 6-min walking distance; SPPB: short physical performance battery; BBS: berg balance scale; s: second; cm: centimeter; AU: arbitrary units; m: meter; kg: kilogram; x: the number of training days per week.
The principles of exercise prescription during COVID-19.
| References | Duration; | Intensity | Time | Type | Volume | Progression |
|---|---|---|---|---|---|---|
| [ | 20 sessions; | NA | 1 h | Proprioceptive | NA | NA |
| [ | 12 wk; | NA | NA | Exergames | NA | NA |
| [ | 7 wk; | NA | 20 min | Mobility | NA | NA |
| [ | 8 wk; | NA | 40 min | Strength; balance; | NA | NA |
| [ | 6 months; | NA | NA | Strength | 15 rep | Increase sets/rep |
NA: not applicable; wk: week; d: day; x: the number of training days per week; min: minute; h: hour; rep: repetitions.
The main outcomes during COVID-19.
| References | Outcomes (Δ) | Pre | Post | Diff. Pre-Post |
|---|---|---|---|---|
| [ | Chair-stand-test | 14 | 16 | 2 (rep) |
| Handgrip strength | 30.04 | 28.2 | −2.2 (kg) | |
| Mini-BEST test | 25 | 26 | 1 (AU) | |
| Thigh extensors strength | 333 | 329 | −4 (n) | |
| Thigh flexors strength | 176 | 178 | 2 (n) | |
| [ | KSS knee score | 49.7 | 89.5 | 39.8 (AU) |
| KSS function score | 37.02 | 91.8 | 54.6 (AU) | |
| ROM | 88.2 | 116.7 | 28.5 (°) | |
| VAS | 5.5 | 0.8 | −4.7 (AU) | |
| [ | Tandem stance | 68.1 | 96.4 | 28.3 (s) |
| TUG | 44.4 | 35.5 | −8.9 (s) |
Diff.: difference; KSS: Knee Society Score; ROM: range of motion; VAS: visual analogue scale; TUG: timed up and go; rep: repetitions; kg: kilogram; AU: arbitrary units; n: Newton; °: degree; s: second.
The principles of exercise prescription of chronic diseases during COVID-19.
| References | Duration; | Intensity | Time | Type | Volume | Progression |
|---|---|---|---|---|---|---|
| [ | 2 wk | NA | NA | Exergames | NA | NA |
| [ | 8 wk | NA | NA | Virtual realty | NA | NA |
| [ | 8 wk | NA | NA | HIIT | NA | NA |
| [ | 12 wk; | NA | NA | Strength; | NA | NA |
| [ | 4 months; | NA | NA | Walking; | NA | NA |
| [ | 16 wk | NA | NA | Strength-resistance | 8–10 rep | NA |
| [ | 6 months | NA | NA | Resistance | NA | NA |
| [ | Daily | NA | 10 min | Walking | NA | NA |
NA: not applicable; wk: week; d: day; x: the number of training days per week; min: minute; HIIT: high intensity interval training; rep: repetitions.
The main outcomes of chronic diseases during COVID-19.
| References | Outcomes (Δ) | Pre | Post | Diff. Pre-Post |
|---|---|---|---|---|
| [ | Chair-stand-test | 14 | 16 | 2 (rep) |
| Handgrip strength | 30.04 | 28.2 | −2.2 (kg) | |
| Mini-BEST test | 25 | 26 | 1 (AU) | |
| Thigh extensors strength | 333 | 329 | −4 (n) | |
| Thigh flexors strength | 176 | 178 | 2 (n) | |
| [ | Arm curl | 18.6 | 21.8 | 3.2 (rep) |
| Chair stand | 14.3 | 16.6 | 2.3 (rep) | |
| Back scratch | −6.1 | 4 | 2.1 (cm) | |
| Sit and reach | 0.7 | 3.4 | 2.7 (cm) | |
| Up and go | 6 | 5.3 | −0.7 (s) | |
| 6MWT | 469.9 | 508.4 | 38.5 (m) | |
| [ | SPPB | 6.78 | 8.43 | 1.65 (AU) |
| CRQ-dyspnea | 2.22 | 2.96 | 0.74 (AU) | |
| CRQ-fatigue | 3.11 | 3.27 | 0.16 (AU) | |
| CRQ-emotional | 3.85 | 4.36 | 0.51 (AU) | |
| CRQ-mastery | 3.83 | 4.22 | 0.39 (AU) | |
| [ | Barthel Index | 54.17 | 82.5 | 28.33 (AU) |
| FAC | 0 | 3.33 | 3.33 (AU) | |
| Hip flexion | 28.33 | 107.5 | 79.17 (°) | |
| Hip abduction | 11.67 | 35.83 | 24.16 (°) |
Diff.: difference; 6MWT: 6-min walking test; SPPB: short physical performance battery; CRQ: chronic respiratory questionnaire; FAC: Functional Ambulation Category; rep: repetition; kg: kilogram; AU: arbitrary units; n: Newton; cm: centimeter; s: second; m: meter; °: degree.